| 502 | N | 205831 | 001 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 10MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | No | RX | RHODES PHARMACEUTICALS LP | 15ff0f26784c4c42c148a5e184c65d355e02df8d47ad79bca5e5283d22bbab94 |
| 503 | N | 205831 | 002 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 15MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | No | RX | RHODES PHARMACEUTICALS LP | 51e92911d606667ac3330968477a3f7dbc44241aac9e69048cbbf36effb96485 |
| 504 | N | 205831 | 003 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 20MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | No | RX | RHODES PHARMACEUTICALS LP | bef3811c1c595aa435203107b9c11dacb443da0806de2ff10295ab624805104d |
| 505 | N | 205831 | 004 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 30MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | No | RX | RHODES PHARMACEUTICALS LP | c6468bf3dc00afdd29e1d4894e5c88b43d2c9ce639f15e3d234fd43f089820c9 |
| 506 | N | 205831 | 005 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 40MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | No | RX | RHODES PHARMACEUTICALS LP | 3c800bcc8e3fb70a6ddc5c51df2ee9ddfde67e43bba4a1642892444ddf94dd0a |
| 507 | N | 205831 | 006 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 50MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | No | RX | RHODES PHARMACEUTICALS LP | 688c278732ee2d66d8000a2dc80481938a051117b36512cbb3a90826e9bcdf4a |
| 508 | N | 205831 | 007 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APTENSIO XR | RHODES PHARMS | 60MG | AB3 | ["AB3"] | 2015-04-17 | Apr 17, 2015 | No | Yes | Yes | RX | RHODES PHARMACEUTICALS LP | 703bc56104ab8bd8a5ccaf9a980d432ea8f386f244286a05fd50eb99eaaa4df5 |
| 509 | N | 006773 | 010 | TRIHEXYPHENIDYL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ARTANE | LEDERLE | 5MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO | 62b79b036160b1288f9c72f68758a814c13fbf4852e4c55e2126ca559eb492aa |
| 510 | N | 012947 | 001 | TRIHEXYPHENIDYL HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ARTANE | LEDERLE | 5MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO | 4bd84678d530f5157f45813922ce135b4087c775aa48052bb89c7868066ade9f |
| 511 | A | 206392 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | AMNEAL PHARMS | 25MG;200MG | AB | ["AB"] | 2016-03-08 | Mar 8, 2016 | No | No | No | RX | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 6773aa4f65462340513794d0d76444222671fbe727e303a952f981110c5fd752 |
| 512 | A | 206964 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | ANI PHARMS INC | 25MG;200MG | | [] | 2017-01-18 | Jan 18, 2017 | No | No | No | DISCN | ANI PHARMACEUTICALS INC | cabfa9a23fb82ec08d07ec91e2df82dfcd0cffe3b8e70df3edcb3df606d4623f |
| 513 | A | 078804 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | BARR | 25MG;200MG | AB | ["AB"] | 2009-08-14 | Aug 14, 2009 | No | No | No | RX | BARR LABORATORIES INC | d0201dd3dffaf4739853e0ddbca7838450274689ab068e8b7fe5a56fc53b8288 |
| 514 | A | 209048 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | DR REDDYS | 25MG;200MG | AB | ["AB"] | 2018-10-10 | Oct 10, 2018 | No | No | No | RX | DR REDDYS LABORATORIES LTD | 5307bc026e80a9fd6b9096cea706a20e659ee361ff7068d8150037235ed4e34c |
| 515 | A | 210318 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | GLENMARK PHARMS SA | 25MG;200MG | AB | ["AB"] | 2019-05-24 | May 24, 2019 | No | No | No | RX | GLENMARK PHARMACEUTICALS SA SWITZERLAND | 0a92d4d24e24874227128220b041b6eb8904c63b3e8bae3eac21677194fdc8d6 |
| 516 | A | 204552 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | LANNETT CO INC | 25MG;200MG | AB | ["AB"] | 2019-03-20 | Mar 20, 2019 | No | No | No | RX | LANNETT CO INC | 5f5f15cd7aedca5fccdac6ef8422bce648efd2ff0d4cd090e8353e32c77482bd |
| 517 | A | 207944 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | PAR PHARM INC | 25MG;200MG | AB | ["AB"] | 2017-01-18 | Jan 18, 2017 | No | No | No | RX | PAR PHARMACEUTICAL INC | f75db905f04a1f3766f9630d315f8b07e85a3cd54551d9fff97938ead6a99201 |
| 518 | A | 206739 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | SANDOZ INC | 25MG;200MG | AB | ["AB"] | 2017-01-18 | Jan 18, 2017 | No | No | No | RX | SANDOZ INC | 2662423f1f421b85a795e9c9a4d7fe055e354779daaceb5fb246bb0e6d9aaa31 |
| 519 | A | 208572 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | SUN PHARM | 25MG;200MG | AB | ["AB"] | 2018-08-21 | Aug 21, 2018 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 0c7303a2646c8270e02bd02af5953fa3ae250471979252b7fd0875f6ffad9208 |
| 520 | A | 206753 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASPIRIN AND DIPYRIDAMOLE | ZYDUS PHARMS | 25MG;200MG | AB | ["AB"] | 2017-08-29 | Aug 29, 2017 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 2b24caaefe44f12ec18385627b98a3a84609adf184db95e42caf00f0bb7dd59c |
| 521 | N | 204096 | 001 | TACROLIMUS | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASTAGRAF XL | ASTELLAS | EQ 0.5MG BASE | | [] | 2013-07-19 | Jul 19, 2013 | No | Yes | No | RX | ASTELLAS PHARMA US INC | 2fda5a52e5c5af644db141eb7440eef4fbc2997e9a9be5c206feec55f6f8690d |
| 522 | N | 204096 | 002 | TACROLIMUS | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASTAGRAF XL | ASTELLAS | EQ 1MG BASE | | [] | 2013-07-19 | Jul 19, 2013 | No | Yes | No | RX | ASTELLAS PHARMA US INC | 3f11ffb39f26f138d02e18c60db54cbf97c2f81ef845f051ba1580d07bf32510 |
| 523 | N | 204096 | 003 | TACROLIMUS | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ASTAGRAF XL | ASTELLAS | EQ 5MG BASE | | [] | 2013-07-19 | Jul 19, 2013 | No | Yes | Yes | RX | ASTELLAS PHARMA US INC | 798ae832c30666d5d62e6c2e29d7bc97776f2de15c5bcf88fbfeb7784b92d193 |
| 524 | N | 021260 | 001 | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AVINZA | KING PHARMS LLC | 30MG | | [] | 2002-03-20 | Mar 20, 2002 | No | No | No | DISCN | KING PHARMACEUTICALS LLC | ba1fe57f02ea68cd07103be7f760d13ec96be3416c499f527c4be6bde00a414d |
| 525 | N | 021260 | 005 | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AVINZA | KING PHARMS LLC | 45MG | | [] | 2008-12-18 | Dec 18, 2008 | No | No | No | DISCN | KING PHARMACEUTICALS LLC | aa3f1ac3eba7baa0052ddf3079b6ab4b26ceda82fdbfab1ed31a856824f0f59e |
| 526 | N | 021260 | 002 | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AVINZA | KING PHARMS LLC | 60MG | | [] | 2002-03-20 | Mar 20, 2002 | No | No | No | DISCN | KING PHARMACEUTICALS LLC | 44450131010f55e60e074904b0c859354dd6229e586a34645d0b11d0968e3007 |
| 527 | N | 021260 | 006 | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AVINZA | KING PHARMS LLC | 75MG | | [] | 2008-12-18 | Dec 18, 2008 | No | No | No | DISCN | KING PHARMACEUTICALS LLC | 99fc56381a63ee458daf44db0bf672209acbb254a21c1532de4400bec9331694 |
| 528 | N | 021260 | 003 | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AVINZA | KING PHARMS LLC | 90MG | | [] | 2002-03-20 | Mar 20, 2002 | No | No | No | DISCN | KING PHARMACEUTICALS LLC | e6518819423c9dc5c6f10c5a54801db23d38287edb3cd6069c66c0f70301a8ca |
| 529 | N | 021260 | 004 | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AVINZA | KING PHARMS LLC | 120MG | | [] | 2002-03-20 | Mar 20, 2002 | No | No | No | DISCN | KING PHARMACEUTICALS LLC | f151f1c22ca91271f59921792311e1acdd47e0ce8ca239222551873bd7155eae |
| 530 | N | 010093 | 007 | AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | BIPHETAMINE 12.5 | UCB INC | EQ 6.25MG BASE;EQ 6.25MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | UCB INC | e9ed2a3a67c9baef468371a073b68542c36def8be6a3c2c6eabfc6b0f81bd002 |
| 531 | N | 010093 | 003 | AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | BIPHETAMINE 20 | UCB INC | EQ 10MG BASE;EQ 10MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | UCB INC | 7a43bcf244eeae01d8622b5a46ac8440fab4827fca74eebd7a14e7f3e6a6f16d |
| 532 | N | 010093 | 009 | AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | BIPHETAMINE 7.5 | UCB INC | EQ 3.75MG BASE;EQ 3.75MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | UCB INC | da3dabeabff880d7f3c7ed53750740023ac785c00a457ad5dfbd303f8fdd12d8 |
| 533 | A | 088021 | 001 | PHENDIMETRAZINE TARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | BONTRIL | VALEANT | 105MG | | [] | 1982-09-21 | Sep 21, 1982 | No | No | No | DISCN | VALEANT PHARMACEUTICALS INTERNATIONAL | 6067466a8c1c389be5587c4453ea1c757d79d4d3da521455aa658a6911eb369a |
| 534 | A | 078986 | 001 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | APOTEX INC | 100MG | AB | ["AB"] | 2011-11-25 | Nov 25, 2011 | No | No | No | RX | APOTEX INC | 2e744fef2c70cbbbfcb423f47d7c62cf0c6dcb72431ddfbf98f86fcbe997b841 |
| 535 | A | 078986 | 002 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | APOTEX INC | 200MG | AB | ["AB"] | 2011-11-25 | Nov 25, 2011 | No | No | No | RX | APOTEX INC | 344f163c3b673c80bb717bbb3c37b4883bd09b76d6e16d337e8421c3400632dd |
| 536 | A | 078986 | 003 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | APOTEX INC | 300MG | AB | ["AB"] | 2011-11-25 | Nov 25, 2011 | No | No | No | RX | APOTEX INC | 95957e03583b0665a3cb1eb2bb821ad4e0750d50c6250f7a9ba75fbe5f3b94c5 |
| 537 | A | 076697 | 001 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | NOSTRUM LABS INC | 100MG | AB | ["AB"] | 2011-05-20 | May 20, 2011 | No | No | No | RX | NOSTRUM LABORATORIES INC | b1e49d46f837d182a8fce74ffb614bbefdd8dbef873f44e70d16bc7eb208f10e |
| 538 | A | 076697 | 002 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | NOSTRUM LABS INC | 200MG | AB | ["AB"] | 2011-05-20 | May 20, 2011 | No | No | No | RX | NOSTRUM LABORATORIES INC | 3b10f01a046330f4a8f62ada4b47d058cde8f84d8dc6093566feae038575e0d6 |
| 539 | A | 076697 | 003 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | NOSTRUM LABS INC | 300MG | AB | ["AB"] | 2011-05-20 | May 20, 2011 | No | No | No | RX | NOSTRUM LABORATORIES INC | 5e5d2c8e69d7bddb8b3ce01e03f20817a48913e22286196527e31408b4f8d006 |
| 540 | A | 201106 | 001 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | TARO | 100MG | AB | ["AB"] | 2013-06-21 | Jun 21, 2013 | No | No | No | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | 76b713985acca920e9e4c874d899b31d1b1dd8c68cb6b208214ca2359c68d4fb |
| 541 | A | 201106 | 002 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | TARO | 200MG | AB | ["AB"] | 2013-06-21 | Jun 21, 2013 | No | No | No | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | c670d58814a4507e89c94f11d8899377c278d3ff3d1b430d942504f28922cf41 |
| 542 | A | 201106 | 003 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | TARO | 300MG | AB | ["AB"] | 2013-06-21 | Jun 21, 2013 | No | No | No | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | ea495dc0a92286ff8c4f3b54d3724272d5740a9ffb9756981f2be1911cca6ec8 |
| 543 | A | 078592 | 001 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | TEVA PHARMS | 100MG | AB | ["AB"] | 2012-09-20 | Sep 20, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | cf750e98613486cd8d9d98e616caca88f7c50ccb641a77ad8e5a1450853080a5 |
| 544 | A | 078592 | 002 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | TEVA PHARMS | 200MG | AB | ["AB"] | 2012-09-20 | Sep 20, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 2e0f1e8b6bd199f3cbb6129134024980d603a2b14d344f03d27ae67a0b753b9e |
| 545 | A | 078592 | 003 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBAMAZEPINE | TEVA PHARMS | 300MG | AB | ["AB"] | 2012-09-20 | Sep 20, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 8c517e4ef26ae38dd872349b0d629a9a80925f6cd81975a0451d62f281f5f799 |
| 546 | N | 020712 | 003 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBATROL | TAKEDA PHARMS USA | 100MG | AB | ["AB"] | 1997-09-30 | Sep 30, 1997 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | 370e7d9ec06ee97ffdcf443ad48ca49552d383f2c0274dc558ea1e154aef8972 |
| 547 | N | 020712 | 001 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBATROL | TAKEDA PHARMS USA | 200MG | AB | ["AB"] | 1997-09-30 | Sep 30, 1997 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | cd1d7fb0223bbe6a9aa5cb9e7c830b96250fc8b11353eda41b255f22bfe73d6f |
| 548 | N | 020712 | 002 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARBATROL | TAKEDA PHARMS USA | 300MG | AB | ["AB"] | 1997-09-30 | Sep 30, 1997 | No | Yes | Yes | RX | TAKEDA PHARMACEUTICALS USA INC | 52da47a3a15810a327446d8ff3da4a5dee166eed2ce3bd8ea417538652b94818 |
| 549 | N | 020005 | 001 | NICARDIPINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARDENE SR | CHIESI | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1992-02-21 | Feb 21, 1992 | No | Yes | No | DISCN | CHIESI USA INC | da93630b2ac91cb8cb9500dd9d3d2018b9048dc9e570baba19552a00e1e64177 |
| 550 | N | 020005 | 002 | NICARDIPINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARDENE SR | CHIESI | 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1992-02-21 | Feb 21, 1992 | No | Yes | No | DISCN | CHIESI USA INC | 314e54742b74d583e7cddfc21890da8ae48e189a2a388969b01c2c81f26c879f |
| 551 | N | 020005 | 003 | NICARDIPINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | CARDENE SR | CHIESI | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1992-02-21 | Feb 21, 1992 | No | Yes | No | DISCN | CHIESI USA INC | 0b17032edb7c9ef8e9247329a613aaa3889854e405f909a885d82fab4e69768c |